(Q42454847)

English

Eicosanoids in sickle cell disease: potential relevance of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid to the pathophysiology of vaso-occlusion

scientific article published on April 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Eicosanoids in sickle cell disease: potential relevance of 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid to the pathophysiology of vaso-occlusion (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

sickle-cell disease

0 references

pathophysiology

1 reference

based on heuristic

inferred from title

author name string

Setty BN

1

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Chen D

2

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

O'Neal P

3

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Littrell JB

4

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Grossman MH

5

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Stuart MJ

6

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

publication date

1 April 1998

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Translational Research

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

131

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

344-353

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Hydroxyeicosatetraenoic acids (HETEs).

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

Brain microvessels produce 12-hydroxyeicosatetraenoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

The lipoxygenase metabolite 12(S)-HETE induces a cytoskeleton-dependent increase in surface expression of integrin alpha IIb beta 3 on melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

Protein kinase C-dependent effects of 12(S)-HETE on endothelial cell vitronectin receptor and fibronectin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

12(S)-HETE promotes tumor-cell adhesion by increasing surface expression of alpha V beta 3 integrins on endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

Lipoxygenase metabolites induced expression of adhesion molecules and transendothelial migration of monocyte-like HL-60 cells is linked to protein kinase C activation

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

Identification of prostaglandins and hydroxyeicosatetraenoic acids in kitten retina: Comparison with other species

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

Demonstration of vasoproliferative activity from mammalian retina

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,14-eicosatetraenoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

12(S)-HETE is a mitogenic factor for microvascular endothelial cells: its potential role in angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

Age-related increase in the migration of aortic smooth muscle cells induced by 12-L-hydroxy-5,8,10,14-eicosatetranoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

12 -Hydroxyeicosatetraenoic acid plays a central role in the regulation of platelet activation

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

15-Hydroxy-5,8,11,13-eicosatetraenoic acid inhibits human vascular cyclooxygenase. Potential role in diabetic vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

12-Hydroxyeicosatetraenoic acid reduces prostacyclin production by endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

Formation of hydroxyeicosatetraenoic acids (HETE) in blood from adults versus neonates: reduced production of 12-HETE in cord blood

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

GMP-140: A receptor for neutrophils and monocytes on activated platelets and endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

Histamine stimulation of prostaglandin and HETE synthesis in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

Regulation of synthesis of prostacyclin and HETEs in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

Hypothesis: is soluble P-selectin a new marker of platelet activation?

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

Effects of desmopressin on circulating P-selectin

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

Significance of plasma β-thromboglobulin values in patients with sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

A study of beta-thromboglobulin and platelet factor-4 plasma levels in steady state sickle cell patients

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

Platelet activation during pain crisis in sickle cell anemia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

Platelet regulatory prostanoids and platelet release products in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

Elevated urinary levels of thromboxane and prostacyclin metabolities in sickle cell disease reflects activated platelets in the circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

Increased in vivo production of thromboxane in patients with sickle cell disease is accompanied by an impairment of platelet functions to the thromboxane A2 agonist U46619

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

Sickle Cell Vaso-occlusive Crisis Is Associated with Abnormalities in the Ratio of Vasoconstrictor to Vasodilator Prostanoids

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2898%2990185-8

7 January 2021

Identifiers

10.1016/S0022-2143(98)90185-8

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42454847&oldid=1958079641"